Batch Contamination Investigation

Batch Contamination Investigation designates the structured quality investigation process undertaken when microbial, chemical, or particulate contamination is detected in a pharmaceutical batch, systematically identifying contamination sources, assessing product impact, determining batch disposition, and implementing corrective actions preventing recurrence.

The biopharmaceutical industry follows rigorous investigation protocols when contamination is detected, as patient safety implications of contaminated injectable products are severe. Investigations employ root cause analysis tools including fishbone diagrams and fault tree analysis examining materials, methods, equipment, environment, and personnel as potential sources. Environmental monitoring data is trended to identify patterns preceding contamination events. Microbial contamination requires organism identification and typing to link to potential sources. Chemical contamination investigations employ analytical chemistry characterising contaminant identity and origin. Regulatory reporting requirements address timelines for notifying authorities of confirmed contamination. Corrective and preventive actions address identified root causes through procedural, equipment, facility, or training improvements. Investigations close only when root causes are confirmed and corrective actions implemented.